The Verdict — IREN Limited (IREN)
Rating | High-risk bearish / avoid at the current price, but not high-conviction |
Current price | $40.20 |
Our fair-value range | $18-$25/share |
Business quality | Very weak |
IREN is overvalued on the core evidence because the current price assumes successful AI deployments, strong cash margins, dependable funding, and controlled dilution before those outcomes are proven in results.
What the market is betting on
IREN operates renewable-powered data centers for Bitcoin mining and AI computing. At $40.20, the current price only makes sense if year-five free cash flow (the cash left after all expenses), before debt payments, reaches approximately $1.39 billion. That requires a 39.7% margin on $3.5 billion of base-case revenue. Yet no Microsoft tranches had been delivered by March 2026. The $3.1 billion of contracted annual recurring revenue was also not fully revenue-generating. Trailing free cash flow was negative $1.11 billion. This gap matters because the valuation capitalizes much of the AI contract promise before deployment, customer acceptance, and reliable cash-flow proof.
What the filings actually show
The filings show rapid AI growth and substantial liquidity, but weak cash economics, heavy commitments, dilution, and major execution risk.
Nine-month revenue rose 81.6% to $569.8 million, although the latest quarter was flat year over year during the transition period.
AI Cloud revenue rose 518.0% to $58.3 million, but contracted demand remained dependent on delivery, commissioning, hours, pricing, and assumptions.
Cash reached $2.213 billion at March 31, while total commitments reached $11.902 billion, with $11.899 billion payable within 12 months.
Trailing free cash flow was negative $1.11 billion, showing the capital-intensive expansion was not yet self-funding from reported operations alone.
Pro-forma shares increased 38.5%, while nine-month stock-based compensation reached $162.1 million, equal to a very high 28.5% of reported revenue.
Metric | Now | A year ago |
|---|---|---|
Nine-month consolidated revenue growth — growth through the business transition | $569.8m | $313.7m |
Quarterly segment gross margin excluding depreciation and amortization — profitability before heavy asset costs | 72.4% | 71.0% |
Nine-month net cash from operating activities — cash generated from reported operations | $289.3m | $142.7m |
Nine-month total stock-based compensation expense — recurring cost borne by shareholders | $162.1m | $23.9m |
Latest fiscal-year diluted weighted shares — ownership dilution across annual reporting periods | 223.2m | 99.6m |
Three ways this plays out
If things break down: The investable stress frame is $5-$10/share if deployments slip, funding tightens, impairments expand, or AI cash margins disappoint. Specialized assets offer some balance-sheet support, but they are not equivalent to cash.
Most likely: Our analysis puts core fair value at $18-$25/share. That range is anchored by the $20 base valuation model and a deliberately conservative 2.5x-3.5x contracted-revenue cross-check before currently unavailable lease adjustments.
If the bulls are right: Conditional upside is $45-$55/share only with timely deployments, conversion of contracted revenue, approximately 25% mature cash margins, strong execution, and no material dilution beyond the valuation share base used.
What would change our mind
Microsoft tranches are accepted and generate revenue without material credits, refunds, or reported delivery delays.
Contracted revenue converts into repeatable operating profit and positive free cash flow after growth investment.
Share growth and stock-based compensation fall sharply without reliance on the $6 billion share-sale program.
This is the compressed view. The full deep-dive — DCF scenarios, the complete scorecard, earnings-quality checks, and every risk we flagged — is available to TradeOS AI members: Read the full IREN report →
This newsletter is for informational and educational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. The analysis is based on public filings and involves estimates that may prove wrong. Do your own research and consider consulting a licensed financial advisor. The author may hold positions in securities mentioned.